Potential Cure For HIV Successfully Completes Pre-investigational New Drug (Pre-Ind) Stage Of FDA Approval Process

LOS ANGELES: LOS ANGELES, Oct. 19, 2021 /PRNewswire/ -- (NASDAQ: ENOB) − A potential cure for HIV, developed by pioneering research scientist Dr. Serhat Gumrukçu, Director of the Seraph Research Institute (SRI), and his team have successfully completed the Pre-Investigational New Drug (IND) process for the U.S. Food and Drug...

Click to view original post